reacquires

Related by string. Reacquire . Reacquires . reacquire * * reacquire Thome . reacquire Hairston younger . peacefully reacquire . reacquire Ivey *

Related by context. All words. (Click for frequent words.) 56 acquires 54 sublicensee 54 Acquires Exclusive 53 aquires 52 Reacquires 51 Sanctura 50 commercialize telaprevir 50 ELESTAT intellectual property 50 Terminates Agreement 50 Cassidy Turley represented 50 Renews Expands 49 Announces License Agreement 49 Vantas 49 Elestat intellectual property 49 autoinjector device 49 Naglazyme R 49 Secures Exclusive 49 Milestone Payments 49 CresaPartners represented 49 Obtains Exclusive 49 Aquires 49 Vertex retains 48 Finalizes Purchase 48 Announce Licensing Agreement 48 commercialize becocalcidiol patented 48 BioOne Corporation 48 Gentamicin Surgical Implant 48 Announce Merger Agreement 48 ProQuin XR 48 Shareholder Opposes 48 Zindaclin 48 FY# Loss Narrows 48 Zovirax ® 48 narrows 1Q loss 48 reacquisition 48 Announces Discontinuation 48 Shareholders Approve Sale 47 TM MMP Portfolio 47 Announce Licensing 47 Adaptec disclaims 47 exclusive sublicense 47 Reacquire 47 Settle Patent Dispute 47 Kawagib Moro human 47 Allos retains exclusive 47 Enters Into Licensing Agreement 47 BioAssets 47 Aradigm Logo 47 Inks License 47 Successfully Completes Tender Offer 47 Signs Licensing 47 JPI JJB 47 pSivida owns 47 Enters Exclusive 47 Exploring Strategic Alternatives 47 Albugon 47 Captisol ® 47 Completes Disposition 46 Neurobionix 46 RenaZorb 46 Subsidiary Enters 46 Taisho Pharmaceuticals 46 Zeneus 46 sublicensed 46 Campto 46 Amends Agreement 46 Vascular Biogenics 46 relapsed refractory pediatric 46 successfully commercialize Silenor 46 kaBOOM 46 Terminate Merger Agreement 46 Secures Long Term 46 BioSyent Pharma 46 Rinat Neuroscience 46 Tego Biosciences 46 Completes Financing 46 Director Exercises Options 46 Exercises Option 46 Stavzor TM 46 successfully commercialize Iluvien 46 Milestone Payment From 46 Closes Acquisition Of 46 LFRP 46 Sign License Agreement 46 Solvay Trilipix 46 Beats Estimates Analyst Blog 46 Amends Existing 46 Holders Approve 46 Signs Definitive 46 Acapodene R 46 reacquire 46 Obtains License 46 Zymo 46 CRESA Partners represented 46 Inc MYL MYL 46 Andrx Pharmaceuticals 46 Inc. Nasdaq REFR 46 evYsio Medical Devices 46 Nascobal 46 Closes Financing 46 Consummates 45 Enters Into License Agreement 45 Completes Purchase Of 45 Explores Strategic Alternatives 45 Completes Previously Announced 45 targeted anticancer biopharmaceuticals 45 CKx owns 45 UGL Equis represented 45 Syntonix 45 Shareholders Approve Acquisition 45 Returns Royalty 45 Commences Tender Offers 45 obligations hereunder 45 Underwriters Exercise Over Allotment 45 CuraGen patents 45 Receives Shareholder Approval 45 CIP TRAMADOL ER 45 including priceline mortgage 45 Exec Joins 45 Announces Tentative Approval 45 Settles Patent Suit 45 CYCLOSET ® 45 SVP Exercises Options 45 Teveten 45 Chiesi Farmaceutici SpA 45 MedGenesis 45 cosmetic cosmeceutical products 45 Caliper microfluidics 45 co licensor KDL 45 AcryMed Incorporated 45 Acqusition 45 Enters Into Definitive 45 biotherapeutic drugs 45 Kyorin Pharmaceutical 45 Epson disclaims 45 Akorn Strides 45 CFO Exercises Options 45 LUCASSIN 45 EyeTel 45 FTC Clears 45 Movers Roundup 45 InterfeRx 45 Files Shelf Registration Statement 45 Terminates Merger Agreement 45 GEM #S R 45 Completes Merger With 45 Q2 Profit Soars 45 Settles Dispute 45 Prometheus Laboratories 45 MethyPatch 45 narrows 4Q loss 45 Acquires Majority 45 Posts Narrower 4Q Loss 45 Apokyn R 45 Senior VP Exercises 45 Exalgo ™ 44 obtains 44 called Microstructure Chromatograph 44 ZBx 44 Agenerase 44 Rhein Biotech GmbH 44 REMICADE infliximab 44 Loramyc ™ 44 Amends Terms 44 Begins Tender Offer 44 Par Pharma 44 Rexahn licensees 44 Monetizes 44 Exercises Warrants 44 VP Exercises Options 44 Receives Favorable 44 FY# Loss Widens 44 ImmunoGen maytansinoid TAP 44 Announces Recapitalization 44 Third Quarter Loss Widens 44 NeutroSpec TM 44 Enpath ability 44 Clarifies Status 44 By Fred Topel 44 Completes Asset 44 Acquires Controlling Interest 44 Buy Privately Held 44 Kyowa Kirin 44 Miraculins Announces 44 Announce Early Termination 44 Successfully Completes Acquisition 44 VaxImmune 44 Completes Transaction 44 Finalizes Acquisition 44 Receives Milestone Payment 44 Announce Definitive Agreement 44 Durect 44 sublicenses 44 Announces Reverse Split 44 Licensing Pact 44 CysDisplay 44 Closes Previously Announced 44 CEO Exercises Options 44 Receives Conditional 44 SansRosa 44 narrows 3Q loss 44 Nippon Shinyaku 44 POTELLIGENT R Technology 44 Mircette R 44 License Pact 44 adenosine injection 44 Signs Purchase Agreement 44 Signs License Agreement 44 Corp. Joins OTCQX 44 X Ceptor 44 Sets Record Date 44 commercialized DURECT 44 Takes Majority Stake 44 x Immtech 44 grant sublicenses 44 Maxy G# 44 Inks Multi 44 SpeBio joint venture 44 Settles Dispute With 44 Launches Generic Version 44 Marvel Characters 44 Axcan Pharma Holding BV 44 Genpharm 44 Pandel R 44 Board Unanimously Rejects 44 Completes Buyout 44 Handok 44 Announces Repurchase 44 Estrostep 44 fullback Stacy Tutt 44 gets USFDA nod 44 Synera 44 Renews Exclusive 44 Announces Early Termination 44 Completes Recapitalization 44 Finalizes Deal 44 Pennsaid Plus 44 Q1 Profit Decreases 44 adopts poison pill 43 Janssen AI 43 Rapinyl 43 Execute Definitive 43 Vertical Branding develops 43 Submits Application 43 Renegotiates 43 AkaRx 43 Closes Merger 43 generic Lotrel 43 Ludlum Entertainment 43 Announces Debt Settlement 43 reacquired 43 Receives Stockholder Approval 43 Practicar Systems Inc. 43 Shareholders Approve Arrangement 43 Rescula ® 43 Clearford Announces 43 Completes Redemption 43 Arranges Financing 43 Withdraws Offer 43 lists 5BD 43 Kosan motilin agonist 43 Bullish Engulfing Formed 43 retains 43 Sweetens Bid 43 Quark Biotech 43 Neurogen disclaims 43 CBM acreage 43 Endotis 43 Completes Purchase 43 Argatroban 43 Bioniche Teoranta 43 Amends Merger Agreement 43 Signs Licensing Agreement 43 EvaMist 43 Adopts Shareholder Rights 43 RetroMetabolic Drug Design 43 Return NSR royalty 43 DMGI acquires 43 Galenea 43 Valeant Pharma 43 lists 2BD 43 Completes Refinancing 43 Posts Wider 43 JCR Pharmaceuticals holds 43 Makes Unsolicited Bid 43 Outbids 43 Purchases Moore Microprocessor 43 SANCTURA SANCTURA XR VANTAS 43 Sets Quarterly Dividend 43 Signs Merger Agreement 43 Upside Looming 43 5 lipoxygenase inhibitor 43 Licence Agreement 43 Preotact R 43 Picor represented 43 Oasmia 43 DepoBupivacaine TM 43 Trademark License Agreement 43 PER.C6 r 43 CIP FENOFIBRATE 43 Announces Organizational Changes 43 AdMedia Partners Advises 43 anti CD3 monoclonal 43 Settle Litigation 43 Royalty NSR 43 Asubio 43 Extends Tender Offer 43 Realty Advisors represented 43 RESEARCH ALERT Jefferies 43 Amend Merger Agreement 43 Secures Patent 43 Ecoval 43 Phusion Laboratories 43 Ovion 43 CEFF financings subject 43 Q1 Adj 43 HepeX B 43 Sells Entire 43 Completes Debt Refinancing 43 Increases Ownership 43 IIROC Resume 43 Teva Pharma 43 BioSante licensees 43 Completes Private Placement 43 Successfully Closes 43 3M Completes Acquisition 43 Impax generic 43 ViroChem 43 Lexiscan ® 43 About Signature Devices 43 Stedesa 43 Q3 Loss Narrows 43 Fred Topel Image 43 Stockholders Approve Merger 43 Considers Sale 43 NMP# ® 43 outlicensed 43 ficlatuzumab 43 Retains Investor Relations 43 Oryx Pharmaceuticals 43 Las Cruces Cerattepe 43 InterfeRx TM 43 QLT CN 43 Wins Injunction Against 43 Completes Tender Offer 43 Difimicin 43 Virdante 43 Submits Bid 43 Closes Over Allotment 43 VENCO 43 intellectualproperty 43 Inks Exclusive 43 Actient Pharmaceuticals LLC 43 staphylococcal vaccines 43 Ups Bid 43 OmniComm Studios 43 Announces Proposed Acquisition 43 commercialize AzaSite 43 Stockholders Approve Merger Agreement 43 Engages Investor Relations 43 Earnings Scorecard 43 danoprevir 43 Exterran Holdings indirectly 43 2Q Profit Doubles 43 Licensing Deal 42 unit AbD Serotec 42 BioMarin Huxley Ltd. 42 Scoops Up 42 suitablility 42 Norgine BV 42 USVO holds similar 42 Adopts Stockholder Rights 42 Receives Unsolicited 42 Candlesticks Bearish Engulfing 42 vibro tactile 42 Enters Oversold Territory 42 Closes Private Placement 42 Makes Hostile Bid 42 Q2 Adj 42 Seroyal 42 Strengthens Balance Sheet 42 novel emulsion formulation 42 Textool 42 Lordsburg mill comprising 42 Upfront Payment 42 Gaymar Industries 42 Files Revised 42 Restate Financials 42 Announce Shareholder Approval 42 Fesoterodine 42 Master License Agreement 42 MolecularBreeding 42 Terminate Agreement 42 Narrows 2Q 42 sublicensing rights 42 Corporation NASDAQ SANYY 42 Capgold project 42 Acadian Timber 42 Azmacort 42 molecular chaperone regulation 42 Silvue 42 Fayetteville Shale Haynesville Shale 42 Roche SWX ROG 42 Extend Collaboration 42 Exclusive Distribution 42 COLAZAL R 42 FSNA owns 42 Xoma Ltd 42 bareMinerals RareMinerals 42 Adnectin 42 Nipent 42 PharmaBio 42 XERECEPT R 42 ZaBeCor 42 BugOil R 42 KL4 surfactant pipeline 42 Nasacort 42 Shareholders Approve Proposed 42 Secures Financing 42 reacquired defenseman 42 Zygogen 42 Infringes 42 commercialize Vanda 42 candidate deforolimus 42 Mutually Agree 42 Metabasis stockholders 42 Private Placement Oversubscribed 42 Corp. BVF CN 42 Acquire Remaining 42 Pravastatin Sodium Tablets 42 Completes Acquisitions 42 Urocidin TM 42 Biovail Laboratories 42 earnout payments 42 Bearish MACD 42 Obtains Extension 42 Rich Knerr 42 activist Nataliya Estemirova 42 terminates 42 Finalizes Sale 42 NewsBite Downgrade Puts Pressure 42 Uracyst ® 42 Q4 Profit Climbs 42 mutually satisfactory definitive 42 Dynepo TM 42 discontinues 42 ELEVESS 42 Ad Taffy itiBiti Ortsbo 42 sanofi aventis GlaxoSmithKline 42 Eric Mindich initiated 42 Enters Into Letter 42 Risperidone Oral Solution 42 Zeatin 42 incorporate CXA 42 Lanesborough REIT announces 42 Asentar TM 42 Alzheimer Immunotherapy Program 42 Announces Divestiture 42 Celgene Thalomid 42 Files Preliminary Prospectus 42 Completes Spin Off 42 RenaZorb TM 42 ZapMedia applied 42 Announces Consummation 42 Sign Definitive Merger 42 Fortical R 42 Inc. OTCBB MNDP 42 PhiloGene 42 Pravachol cholesterol lowering 42 JUVISTA 42 commercialize Isotechnika lead 42 InvaGen 42 Announces Definitive Agreement 42 Sells Itself 42 Inks Pact 42 ITNation reserves 42 divests 42 buys 42 Finds Buyer 42 Entocort 42 acquisitions divestitures mergers 42 antibody humanization 42 SOLODYN R 42 Acquire Assets 42 Commences Offering 42 evYsio 42 Announces Termination 42 Fortamet 42 asimadoline 42 Targeted Chemotherapy 42 Clean Diesel develops 42 Acquires 42 Spins Off 42 Milestone Payment 42 Neosil 42 Becomes Sole 42 Enters Option Agreement 42 Behcet uveitis 42 Indaflex 42 Patent Infringement Lawsuit Against 42 Q1 Loss Narrows 42 Exalgo TM 42 Vegenics 42 INTUNIV TM 42 Closes Acquisition 42 BIOCEUTICALS 42 Q3 Adj 42 Zenapax 42 Subsidiary Enters Into 42 Reaches Definitive Agreement 42 Sells Shares 42 Alfa Wassermann 42 CapMan Oyj 42 Nova Metrix 42 manufactures minimally invasive 42 Executes Agreement 42 resolves patent infringement 42 Announces Additions 42 CFO resigns 42 Shire plc ADHD 42 Merial Intervet 41 Reversal Soon 41 Medpharm 41 studio Vicious Cycle 41 PharmaSwiss SA 41 Subsidiary Acquires 41 Preotact 41 Completes Reorganization 41 orally disintegrating 41 PRAVACHOL R 41 ADCC enhanced 41 Kissei Pharmaceutical 41 Secures Additional 41 Announces Definitive Merger 41 EHT AGN 41 Nippon Kayaku 41 Decision Imminent 41 Danjaq LLC 41 LifeSync Corporation 41 Securityholders Approve 41 unilaterally terminate 41 Salix Pharma 41 CollaRx GENTAMICIN SURGICAL IMPLANT 41 Shire ADHD 41 Sanofi Aventis Schering Plough 41 Enter Into Definitive 41 Announce Termination 41 GLASSIA 41 Renews Multi 41 sublicense agreements 41 COMPLETE XRM 41 Initiates Voluntary Recall 41 Regeneca 41 Enablex 41 Goes Hostile 41 SangStat Medical Corporation 41 inlicensing 41 Genaera Liquidating Trust 41 Signs Lease 41 Amplimmune 41 Increases Private Placement 41 commercialize elagolix 41 assume operatorship 41 Avinza 41 Synerx 41 MTV Networks Paramount Pictures 41 Transition Therapeutics 41 outlicensing 41 Concludes Acquisition 41 Wins Patent Infringement 41 Nicomide 41 Expands Relationship With 41 Analysts Upgrades Downgrades 41 CORRECTED BRIEF 41 Synerx Pharma 41 Fred Topel Images 41 4Q Profit Doubles 41 Taiho Pharmaceutical 41 Osteocel 41 Visual Voicemail patents 41 required Alkaloida promptly 41 Partners Invests 41 Altoprev 41 Acquires Remaining Interest 41 antidepressant Wellbutrin XL 41 Company Ltd CLJC 41 Closes Second Tranche 41 collagenase clostridium histolyticum 41 Spins Out 41 homocysteine assay 41 md formulations brand 41 H1 Profit Declines 41 Signs Joint Venture 41 Gestiva TM 41 RHEI 41 LOPROX R 41 Canadian drugmaker Aeterna 41 romazarit 41 NOTE MLF 41 secures 41 Reveals Receipt 41 shuffles execs 41 Axenohl 41 Enters Into Merger Agreement 41 Cerner Cerner Cerner Millennium 41 Buy Majority Stake 41 Myriad logo BRACAnalysis 41 Oxandrin ® 41 Amends Credit 41 Completes Reverse Merger 41 lucy activewear inc 41 Teijin Pharma Limited 41 fexofenadine HCl 41 DTLL 41 Buys Majority Stake 41 Signs Multiyear 41 Medicis disclaims 41 reapplies 41 music sharer Napster 41 Enters Into Exclusive 41 sublandlord 41 Seikagaku 41 Betaseron ® 41 Patent Dispute 41 acquired 41 orally disintegrating tablets 41 Completes Restructuring 41 exclusivity 41 Signs Long Term 41 Novexel SA 41 zileuton tablets 41 Q3 Profit Soars 41 Novartis Sandoz 41 OTC ZEGERID 41 Soleus TM software 41 Teikoku Seiyaku 41 cyclobenzaprine hydrochloride extended 41 Lovaza TM 41 Apokyn ® 41 Elan Pharma 41 Signs Distribution 41 fesoterodine 41 Enters Definitive Agreement 41 Glenmark Generics Limited 41 Restructures Debt 41 buys 4BD 41 Ken Heebner initiated 41 Elixir Gaming retains 41 HalcyGen 41 sublicensees 41 subsurface mineral 41 Proprius Pharmaceuticals 41 Lipocine 41 Loss Shrinks 41 Signs Option Agreement 41 Shareholders Approve Merger Agreement 41 Expands Internationally 41 Snaps Up 41 Enters Into Definitive Agreement 41 EVP Exercises Options 41 Extend Partnership 41 topical PTH #-# 41 Luitpold Pharmaceuticals Inc. 41 Wellstat Therapeutics 41 S2 Therapeutics 41 Arius Pharmaceuticals 41 narrows 2Q 41 Premarket Roundup 41 Myotech 41 Christian Laettner Eduardo Najera 41 rabeprazole sodium 41 Helsinn Healthcare SA 41 Commences Cash 41 Receives Confirmation 41 BRILINTA 41 Stockholders Approve 41 XIAPEX 41 lists 3BD 41 Hyprotech 41 Enters Strategic 41 Teikoku Seiyaku Co. 41 Completes Sale Of 41 Restructures Operations 41 Conforma Therapeutics 41 FY# Profit Surges 41 Minera del 41 AeroLEF R 41 Sarnoff TakeCharge 41 Avivo Corporation 41 PPW Toys 41 Broder Bros. Co. 41 Obtains Approval 41 Wins Approval 41 Agencourt Personal Genomics 41 Autodesk Completes Acquisition 41 EpiTherapeutics 41 Approaching Resistance 41 Sign Definitive Agreement 41 RE# [001] 41 POTELLIGENT R 41 Quinapril 41 Files Voluntary Petition 41 spokeswoman Michele Szynal 41 Ruian Auto Parts 41 Corp. OTC SOPK 41 Extends Expiry Date 41 Somatuline R Autogel R 41 Mineralfields Group 41 UDL Laboratories 41 Explore Strategic Alternatives 41 Argentum Silver 41 Enters Into Agreement 41 Announces Cancellation 41 Delatestryl 41 miconazole Lauriad 40 itssubsidiaries 40 Pennsaid R 40 Ironman Levi Strauss 40 Zor Pharmaceuticals 40 Announces Granting 40 entrant hereby waives 40 Seeks Approval 40 Range Tightening 40 Oxcarbazepine 40 Dynepo 40 TSX Delisting Review 40 ViaCord R 40 SynthRx 40 KAI Pharmaceuticals Inc. 40 Expands Distribution 40 BioZone 40 FY# Profit Declines 40 Ethypharm SA 40 Tecomet 40 STRIANT 40 mark LabWindows 40 Finno Ugric minorities 40 digitizing pathology 40 Celltech Pharmaceuticals 40 Terbinafine 40 Newdico 40 HC Van Wyk 40 PluriX 40 Exec Exercises Options 40 Numax 40 Contingent Value Right 40 Dermylex ™ 40 oral PTH technology 40 Agree Realty Announces 40 Teijin Pharma 40 Broadens Its 40 Signs Definitive Purchase Agreement 40 Second Period 5 40 Dobotex 40 Cellceutix owns 40 Movers roundup 40 calcitonin manufacturing 40 CellGate 40 Holds Annual Meeting 40 Closes Private Placements 40 Cellpep 40 Ventures Invests 40 Inc. NASDAQ NXTP 40 Cuts Stake 40 commercialize lorcaserin 40 Announces Affiliation 40 subsidiaries Autoben 40 BAT Diageo 40 Protez Pharmaceuticals 40 antibody humanization patents 40 Estrasorb 40 Russia nationalized Morozov 40 BC SeraPro proteomic 40 Wolf Haldenstein Investigates 40 Nextoy LLC used 40 Signs Definitive Merger Agreement 40 Isis Pharma 40 Forges Partnership 40 ARCALYST R 40 Files Bankruptcy 40 Licensing Agreement 40 Mulgravian 40 Signs Definitive Deal 40 Nycomed GmbH 40 blatantly infringing 40 Les Crudele president 40 Fumapharm AG 40 DIIG 40 OTC Bulletin Board TENF 40 Inc CRIS 40 Acquire Majority 40 Extends Relationship With 40 whereby Marathon PGM 40 Divest Non 40 fexofenadine hydrochloride 40 Orapred ODT 40 Smartstox.com Spotlights 40 CFO Resigns 40 ViroChem Pharma Inc. 40 Q2 Profit Climbs 40 Finalize Agreement 40 posts 2nd qtr 40 Inks Deals 40 Inks Licensing Deal 40 Inc NASDAQ CISG 40 Enjuvia 40 Itero 40 Daytrana ® 40 Aplenzin 40 rights 40 phage display technology 40 QMLP 40 AMRIX 40 Timolol ophthalmic solution 40 Mulls Sale 40 Aganocide TM 40 Faes Farma 40 MediSense 40 Ltd VGR 40 Albert Miralles 40 CIMYM 40 TechMARK movers 40 Rejects Buyout Offer 40 IG CGS ;) CO 40 Starwatch consumer 40 Astellas Deutschland GmbH 40 Xenazine ® 40 sublingual fentanyl 40 Reloxin R 40 Canada Trading Halt 40 Resigns Quick Facts 40 Lumacan 40 Ships #th 40 Zegerid OTC 40 Mangalisa 40 Shareholders Approve Buyout 40 Eric Gagne rhp 40 Announce Commencement 40 pegylated interferon lambda 40 Seikagaku Corporation 40 Considers Selling 40 3Q Profit Tumbles 40 Flutiform TM 40 sees FY opg 40 underpromoted patent protected 40 Posiphen TM 40 FMEC 40 Dyax utilizes 40 Reduces Stake 40 owned Jacor Communications 40 Earnings Rise Sharply 40 cMET inhibitor 40 ADDERALL XR R 40 MorphoSys HuCAL 40 tafluprost 40 Updates Status 40 Sells Remaining 40 Fresenius SE arising 40 Mr. Economo 40 Completes Initial 40 Allegra fexofenadine 40 Announces Effective Date 40 Q4 Adj 40 finical instrument ie 40 STRIANT ® 40 renegotiates 40 RedHill 40 Somatuline Autogel 40 Rejects Unsolicited 40 IIROC Halt 40 Macquarie DDR Trust 40 vancomycin hydrochloride 40 PerClot 40 Bayer Schering 40 UltiMAb R 40 Amikacin Inhale 40 Osmotica 40 azimilide 40 ALZA 40 Finalizes Agreement 40 Proquin XR 40 Obtains 40 owns SCIFI.COM 40 Meda Pharmaceuticals 40 Productions SCI FI 40 Each Broker Warrant 40 Announces Normal Course 40 Grandcru 40 successfully integrate Legerity 40 Benicar HCT 40 Partnering Agreements 40 NWest Energy Inc. 40 Vernalis plc 40 SPRIX ® 40 Inks Supply 40 Confirms Commitment 40 Seek Shareholder Approval 40 ACTCellerate 40 CARBOSOME 40 xi Immtech ability 40 Trims Guidance 40 Kirrin Resources Announces 40 sub licensable 40 candidate SILENOR TM 40 Par Pharmaceuticals 40 Oncolys 40 copromotion 40 analyst Zaineb Bokhari 40 Saponis 40 Mechanicsville Turnpike Richmond 40 Javaris Crittenton Aaron McKie 40 Lower Olinghouse Placers 40 commercialize XL# 40 CB2 selective 40 Q4 Profit Surges 40 Joester Loria Group 40 Announces Successful Completion 40 Sees Profits 40 Filmyard Holdings LLC 40 Tev Tropin 40 NovaScreen Biosciences 40 Retavase 40 Optionees 40 Increases Buyback 40 GlaxoSmithKline Imitrex 40 small molecule thrombopoietin 40 Adjourns Special Meeting 40 refiles 40 Galderma Pharma 40 refusal ROFR 39 Makes Hostile 39 Capital Invests 39 Expands Portfolio 39 CEO Discusses F#Q# [001] 39 Names Successor 39 Display Enhancements 39 unpatented claims 39 BayStreet.ca Research Alert 39 Cardene 39 ScissorTail 39 Taro Pharma 39 Seeks Buyer 39 Equasym 39 Chugai Pharmaceutical Japan 39 Reports 4Q Loss 39 MBMI Closes 39 UAW Reach Tentative 39 Xerclear TM 39 Private Placement Closed 39 Closes Sale 39 Exchangeco 39 whollyowned 39 Sell Portion 39 Fanapt ™ 39 Oral Suspension USP 39 Suspends Quarterly Dividend 39 Hectorol R 39 Chelopech Mining EAD 39 domesticity maven 39 eligen ® 39 SWOT Analysis Aarkstore Enterprise 39 Captisol 39 GlobeSt.com EXCLUSIVE 39 Receives Patent 39 Announces Concurrent Offerings 39 Acquire Remaining Interest 39 Acquire Privately Held 39 Ltd. Acquirer 39 acquire Lexico Publishing 39 NetDeposit LLC 39 Biovitrum develops 39 Dealmaking Profile 39 Announce Receipt 39 Extends Closing Date 39 Teva ANDA 39 Sensipar royalties 39 Pepducin technology 39 Paragraph IV certifications 39 Sonic RoxioNow 39 Signs Non Binding 39 Nitoman 39 Immunicon intellectual property 39 equityholders 39 LSE CVA leading 39 lists 4BD 39 Broadens Product 39 Newly Acquired 39 AllPennyStocks.com Spotlights 39 NMP# ® BladderChek 39 ddRNAi 39 PHSL 39 Allegra ® 39 FY# Profit Rises 39 Q1 adj 39 Handok Pharmaceuticals 39 Delays Filing Annual Report 39 GCMN 39 Significantly Expand 39 KremeKo Inc.

Back to home page